CG

38.4000.52%

Carlyle climbs 5%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Carlyle Group (CG.US) climbed nearly 5% during regular trading to $41.52.

The stock is up 7.17% over the past ten sessions and down 28.26% year to date.

The Nasdaq Composite is little changed over the past five sessions and up 8.36% year to date.

The asset management and custody banks industry index rose 2.5% over the same period.

Carlyle and PAI Partners have agreed to sell women’s health company Theramex to Cinven for 2.6 billion euros, with the transaction expected to close in the first half of 2027. The valuation represents more than double the approximately 1.2 billion euros paid when the consortium acquired the asset in 2022.

Separately, third-quarter fee-related earnings rose 17% year-over-year. Management set a fundraising target of $60 billion for 2026 and returned $24 billion to private equity investors.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.